Illumina Inc

Insider selling at Illumina signals a mixed outlook: senior execs off‑load shares amid volatile earnings and an upcoming NovaSeq X launch, prompting investors to weigh short‑term signals against long‑term growth potential.

Illumina insider selling: Barnard’s 1,259‑share sale signals routine portfolio rebalancing, not a looming decline – investors should watch future filings.